Checked.be
Active
BE 0799.409.266Private limited company
Helsen Pharma & Consulting
Elsum 58 ·2440 Geel, Belgium· 3 yrs active
Sector: NACE 66300
(66300)
Conclusion
The computed 12-month bankruptcy probability of Helsen Pharma & Consulting is 0.1% (very low). The 2024 annual accounts show equity of €24k and a net result of €14k. Its solvency ranks better than 24% of 135 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Key figures
| Equity | €24k |
| Net result | €14k |
| Better than sector | 24% |
| Active | 3 yrs |
Snowflake analysis
54
/ 100
Mixed profile: strong on profitability, weaker on solvency.
Health
35
Profitability
100
Solvency
6
Growth
50
Stability
79
Bankruptcy probability (12 mo)
0.1%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
No administrative flags
Health barometer
35
/ 100
Weak
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative — not credit advice.
Financial overview
Annual accounts filed on 27-06-2025 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 66 · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 9.2% | 35.7% | |
| Net result | €14k | €28k | |
| Equity | €24k | €51k | |
| Gross operating margin | €35k | €62k | |
| Total assets | €262k | €155k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | — |
| Net profit | €14k |
| Cash flow | — |
| Staff costs | — |
| Income taxes | €5k |
| Dividends | — |
| Total assets | €262k |
| Equity | €24k |
| Debt | €238k |
| of which ≤ 1y | €84k |
| of which > 1y | €152k |
| Working capital | €-74k |
| Employees (FTE) | — |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.11 |
| Quick ratio | 0.11 |
| Working capital ratio | -28.4% |
| Solvency | 9.2% |
| Debt / equity | 9.93 |
| Long-term debt ratio | 6.37 |
| Interest coverage | — |
| Gross margin | — |
| Net margin | — |
| ROA | 5.3% |
| ROE | 58.2% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €262k |
| Fixed assets | 21/28 | €252k |
| Financial fixed assets | 28 | €252k |
| Current assets | 29/58 | €10k |
| Cash & bank | 54/58 | €9k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €262k |
| Equity | 10/15 | €24k |
| Contributions / capital | 10/11 | €10k |
| Reserves | 13 | €14k |
| Amounts payable | 17/49 | €238k |
| Amounts payable after one year | 17 | €152k |
| Amounts payable within one year | 42/48 | €84k |
| Trade debts payable within one year | 44 | €1k |
| Income statement | ||
| Gross operating margin | 9900 | €35k |
| Operating result | 9901 | €34k |
| Financial charges | 65 | €15k |
| Result before taxes | 9903 | €19k |
| Income taxes | 67/77 | €5k |
| Net result for the period | 9904 | €14k |
| Result to be appropriated | 9905 | €14k |
Ratios computed by Checked.
Legal Structure
| NACE primary | 66300 |
| Legal form | Private limited company(610) |
| Incorporation | 10-03-2023 |
| Status | Active |
| Postal code | 2440 |
Establishment units
Helsen Pharma & Consulting
since 20232.343.042.126
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13376G0592/00P003 | Flanders | 1,035 m² | 1 · 238 m² | 10.7 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data — this is not proof of ownership.
Updates
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
27-06-2025
NBB filing
Annual accounts filed
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE)
Activities
Vermogensbeheer66300Vermogensbeheer66300Verhuur en exploitatie van eigen of geleasd residentieel onroerend goed, exclusief sociale woningen68201Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen68201Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Overige vormen van onderwijs85599Overige vormen van onderwijs85599
Primary activity highlighted.
Names & trade names
| Legal nameNL | Helsen Pharma & Consulting |
| AbbreviationNL | H P C |
Registered office
Elsum 58
2440 Geel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
VANDERSTRAETEN-DE BRABANDER
BE 0800.876.342 · Deinze
Unoya
BE 0797.731.463 · Gent
ALKIM REAL ESTATE
BE 0780.833.766 · Charleroi
INVEST DE ROUCK
BE 0793.966.279 · Zottegem
YourExpert
BE 0795.521.447 · Knokke-Heist